Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.5K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Tumor Immunotherapy01:27

Tumor Immunotherapy

785
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
785
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

12.4K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
12.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Outcomes of Thromboprophylaxis With Apixaban in Patients With Newly Diagnosed Multiple Myeloma, the MyelMeXa Study.

EJHaem·2026
Same author

Outpatient Delivery of Step-Up Doses to Rapidly Initiate Monthly Doses of Bispecific Antibodies in Multiple Myeloma.

European journal of haematology·2026
Same author

Geographic and Socioeconomic Determinants of Treatment Abandonment in Pediatric Acute Leukemia: A Cohort Study in South-Central Mexico.

Cancer control : journal of the Moffitt Cancer Center·2026
Same author

Impact of standardized immunophenotyping and MRD monitoring on early mortality reduction in childhood leukemia: a step towards addressing healthcare disparities in vulnerable populations from Southern Mexico.

Frontiers in oncology·2025
Same author

Multiple myeloma: retrospective assessment of routine thromboprophylaxis and utility of thrombotic risk scores.

Research and practice in thrombosis and haemostasis·2024
Same author

Implementation of a roadmap for the comprehensive diagnosis, follow-up, and research of childhood leukemias in vulnerable regions of Mexico: results from the PRONAII Strategy.

Frontiers in oncology·2024

Related Experiment Video

Updated: Oct 31, 2025

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma
08:53

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Published on: June 10, 2017

10.2K

Mexican Consensus on Hodgkin's Lymphoma.

José L Álvarez-Vera1, Jocelyn Aguilar-Luevano2, Luisa M Alcívar-Cedeño1

  • 1Servicio de Hematología, Centro Médico Nacional 20 de noviembre, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE), Ciudad de México.

Gaceta Medica De Mexico
|July 1, 2021
PubMed
Summary

Hodgkin's lymphoma arises from transformed B lymphocytes, creating unique Reed-Sternberg cells. Treatment for this B cell malignancy depends on disease subtype, stage, and prognostic factors.

Keywords:
BrentuximabDeauvilleInmunohistochemicalInmunohistoquímicaQuimioterapiaQuimioterapyReed sternbergReed-Sternberg

More Related Videos

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.4K
Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
12:58

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line

Published on: May 10, 2017

9.5K

Related Experiment Videos

Last Updated: Oct 31, 2025

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma
08:53

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Published on: June 10, 2017

10.2K
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.4K
Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
12:58

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line

Published on: May 10, 2017

9.5K

Area of Science:

  • Oncology
  • Hematology
  • Immunology

Background:

  • Hodgkin's lymphoma (HL) originates from B lymphocytes, characterized by pathognomonic Reed-Sternberg cells.
  • This B cell malignancy exhibits a bimodal age distribution, with peaks in young adulthood and later life.
  • HL cells undergo significant gene expression reprogramming, losing B-cell markers and expressing genes from other immune cells.

Purpose of the Study:

  • To summarize the key characteristics of Hodgkin's lymphoma.
  • To outline the factors influencing treatment decisions for Hodgkin's lymphoma.

Main Methods:

  • Review of the pathobiology of Hodgkin's lymphoma.
  • Analysis of epidemiological data regarding incidence.
  • Examination of gene expression patterns in malignant cells.
  • Evaluation of treatment algorithm variables.

Main Results:

  • Hodgkin's lymphoma is a clonal B cell neoplasm characterized by Reed-Sternberg cells.
  • The disease shows a bimodal incidence pattern.
  • Malignant cells exhibit altered gene expression, deviating from typical B-cell profiles.
  • Treatment strategies are tailored based on disease classification, stage, and prognostic indicators.

Conclusions:

  • Hodgkin's lymphoma is a complex B cell malignancy with distinct cellular and molecular features.
  • Personalized treatment approaches are essential for effective management of Hodgkin's lymphoma.